IL1B and prostate cancer: Testosterone deficiency is associated with increased pro-inflammatory cytokines, and testosterone supplementation has been shown to reduce anti-inflammatory cytokines (IL-10) and pro-inflammatory cytokines (IL-1β, IL-6, and TNF-α) in patients with coronary artery disease, prostate cancer and diabetes [67].